Q2 2026 revenue rose 30.4% to $1.7B, with net income up 24.7% and adjusted EPS at $1.07. Organic revenue declined 0.7%, but organic revenue with contingents grew 0.7%. Risks include integration of a major acquisition and market uncertainties.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.